MetLife Investment Management, LLC - PROCEPT BIOROBOTICS CORP ownership

PROCEPT BIOROBOTICS CORP's ticker is and the CUSIP is 74276L105. A total of 128 filers reported holding PROCEPT BIOROBOTICS CORP in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.9%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of PROCEPT BIOROBOTICS CORP
ValueSharesWeighting
Q3 2023$629,755
-7.2%
19,1940.0%0.01%0.0%
Q2 2023$678,508
+73.1%
19,194
+39.1%
0.01%
+66.7%
Q1 2023$391,863
-31.6%
13,7980.0%0.00%
-40.0%
Q4 2022$573,169
+0.2%
13,7980.0%0.01%0.0%
Q3 2022$572,065
+26.8%
13,7980.0%0.01%
+25.0%
Q2 2022$451,057
+157.4%
13,798
+175.5%
0.00%
+300.0%
Q1 2022$175,2305,0080.00%
Other shareholders
PROCEPT BIOROBOTICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
CPMG Inc 10,918,393$382,035,00064.08%
DUMAC, INC. 165,179$5,780,00014.12%
JOHNSON & JOHNSON 1,018,478$35,637,0006.74%
Duquesne Family Office 1,128,041$39,470,0001.71%
Sturgeon Ventures LLP 69,640$2,352,0001.27%
Perceptive Advisors 1,488,284$52,075,0001.04%
Altium Capital Management LP 47,077$1,647,0000.55%
VIKING GLOBAL INVESTORS LP 3,658,892$128,025,0000.52%
Atika Capital Management LLC 58,138$2,034,0000.17%
RTW INVESTMENTS, LP 161,138$5,638,0000.12%
View complete list of PROCEPT BIOROBOTICS CORP shareholders